| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |